Studies in children with CAP [56, 57], hospital-acquired infections [33], severe bronchiolitis [34], and after cardiovascular surgery [32] have shown that PCT levels can be used to safely reduce overall antibiotic use in children. The gene discussed is CALCA; the disease is bronchiolitis.